Key Events This Week
25 May: Stock opens at Rs.731.25, modest gain of 0.49%
26 May: Q4 FY26 results reveal strong quarter but structural concerns emerge
27 May: Record revenue and profit margins announced; technical momentum shifts
29 May: Valuation upgrade signals renewed price attractiveness despite price decline
29 May: Week closes at Rs.645.35, down 11.32% for the week
Why is Jubilant Ingrevia Ltd falling/rising?
2026-05-30 02:02:42
Short-Term Price Performance and Market Comparison
Jubilant Ingrevia’s stock has underperformed significantly over the past week, registering a steep loss of 11.32%, compared to the Sensex’s modest decline of 0.85% during the same period. The one-month performance also shows a sharper fall of 8.06% against the Sensex’s 3.51% drop. Year-to-date, the stock is down 8.33%, though this is slightly better than the broader market’s 12.26% decline. Despite these recent setbacks, the stock has delivered strong returns over the medium term, with a three-year gain of 61.64%, well above the Sensex’s 18.98% rise. However, the five-year return of 33.30% trails the benchmark’s 45.41%, signalling some challenges in sustaining long-term growth.
Technical Indicators and Trading ...
Read full news article
Jubilant Ingrevia Ltd Technical Momentum Shifts Amid Mixed Indicator Signals
2026-05-29 08:04:45Jubilant Ingrevia Ltd, a specialty chemicals company, has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bearish stance. Despite some bullish weekly indicators, monthly signals suggest caution, reflecting a complex interplay of market forces as the stock trades near ₹679.40, down 2.72% on the day.
Read full news article
Jubilant Ingrevia Ltd Valuation Shifts Signal Renewed Price Attractiveness
2026-05-29 08:03:00Jubilant Ingrevia Ltd has witnessed a notable shift in its valuation parameters, moving from a fair to an attractive rating, despite a recent dip in its share price. This change reflects evolving market perceptions and improved relative metrics compared to its specialty chemicals peers, signalling a potential inflection point for investors analysing price-to-earnings and price-to-book value ratios.
Read full news articleAre Jubilant Ingrevia Ltd latest results good or bad?
2026-05-27 20:24:54Jubilant Ingrevia Ltd's latest financial results for the quarter ended March 2026 reflect a notable operational turnaround. The company reported net sales of ₹1,178.65 crores, marking a sequential growth of 12.16% from the previous quarter, which contrasts with a decline of 6.23% in December 2025. This quarter also saw a significant increase in consolidated net profit, which reached ₹86.44 crores, representing an 84.31% rise compared to the prior quarter's profit of ₹46.90 crores. The operating margin for this quarter improved to 13.94%, up by 178 basis points from the previous quarter, indicating enhanced operational efficiency. Additionally, the profit after tax margin rose to 7.41% from 4.51% in the previous quarter, showcasing better cost management and absorption of fixed costs. Despite these positive quarterly results, the company faces challenges in sustaining growth over the long term. The annual ...
Read full news article
Jubilant Ingrevia Ltd Technical Momentum Shifts Amid Mixed Indicator Signals
2026-05-27 08:05:13Jubilant Ingrevia Ltd, a small-cap player in the Specialty Chemicals sector, has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend. Despite a recent downgrade in daily moving averages and a 4.49% drop in share price on 27 May 2026, the stock’s weekly and monthly technical indicators present a complex picture, reflecting both bullish and bearish signals that investors must carefully analyse.
Read full news article
Jubilant Ingrevia Ltd Reports Strong Quarterly Turnaround with Record Revenue and Profit Margins
2026-05-27 08:00:24Jubilant Ingrevia Ltd has delivered a remarkable financial turnaround in the quarter ended March 2026, posting record-high revenue and profitability metrics that mark a significant shift from its previous negative trend. The specialty chemicals company’s latest quarterly results reveal robust growth in net sales, operating profit, and earnings per share, signalling renewed operational strength and improved financial health.
Read full news article







